Dechert advised Biomunex Pharmaceuticals on the deal.Biomunex Pharmaceuticals, a French biopharmaceutical company, closed a strategic exclusive worldwide license and co-development agreement with Onward Therapeutics SA for…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now